Cochrane · systematic review · CD007695
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
Cates, CJ, Lasserson, TJ · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 50%Low 3 · 50%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Show all 2 versionsRegular formoterol compared to regular salmeterol for chronic asthma: serious adverse events
Population: patients with asthma
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause mortality in adults Regular formoterol vs regular salmeterol | no estimate extracted | 3 studies · 1116 participants | Low |
All‐cause mortality in children Regular formoterol vs regular salmeterol | no estimate extracted | 1 study · 156 participants | Very low |
All‐cause SAEs in adults Regular formoterol vs regular salmeterol | OR 0.77 [0.46, 1.28] | 3 studies · 1116 participants | Low |
All‐cause SAEs in children Regular formoterol vs regular salmeterol | OR 0.95 [0.06, 15.33] | 1 study · 156 participants | Very low |
Asthma‐related SAEs in adults Regular formoterol vs regular salmeterol | OR 0.86 [0.29, 2.57] | 3 studies · 1116 participants | Low |
Asthma‐related SAEs in children Regular formoterol vs regular salmeterol | no estimate extracted | 1 study · 156 participants | Very low |